Shanghai Institute for Advanced Immunochemical Studies (SIAIS), affiliated with ShanghaiTech University, was founded on October 12th, 2012. Richard A. Lerner, the founder and pioneer of immunochemistry, is the founding director of SIAIS. With the vision of becoming the “Bell Labs” in biomedical research, SIAIS is growing into a leading international biomedical research institute that values originality and focuses on major diseases, including infectious diseases, autoimmune diseases and other important human diseases.
SIAIS currently comprises 18 laboratories spanning diverse research areas, including infection and immunity, structural biology, AI-driven drug discovery, gene editing, medicinal chemistry, and DNA-encoded library (DEL) technology, among others. For detailed information, please visit us at https://siais.shanghaitech.edu.cn/.
Join Our Institute: Faculty Positions in Biomedical Research and Therapeutic Discovery:
We are inviting exceptional and innovative scientists to apply for multiple tenure-track or tenured faculty positions at our institute. Applicants at all career stages are welcome, provided they are dedicated to advancing biomedical research and therapeutic innovation.
We are particularly interested in candidates focused on disease mechanisms and therapeutic development for autoimmune disorders—including systemic lupus erythematosus, rheumatoid arthritis, axial spondyloarthritis, and ulcerative colitis—as well as in enhancing anti-tumor immunity and addressing infectious diseases such as tuberculosis, coronavirus, and flavivirus infections. While these represent priority areas, we also encourage applications from researchers working in related fields.
We are especially enthusiastic about applicants with expertise in cutting-edge technologies and methodologies, such as (but not limited to): AI-driven drug design, De novo protein design, Bioinformatics, Medicinal chemistry, Chemical biology, Drug modality development.
Candidates who can bridge disease biology with therapeutic innovation—and who have a strong track record or clear potential in translational research that leads to novel drug candidates—are strongly encouraged to apply.
Successful candidates will join a vibrant, interdisciplinary research environment with access to state-of-the-art facilities and extensive opportunities for collaboration across immunology, infectious disease, structural biology, computational science, and drug development.
Qualifications:
Successful applicants should possess a strong educational background and an outstanding research track record in biochemistry, bioengineering, biomedicine, computer science, medicinal chemistry, or a related field. They should demonstrate innovative thinking, scientific independence, and the ability to establish and lead an independent research group. Strong collaboration and teamwork skills are also essential.
Compensation and Benefits:
Salary and startup funds are highly competitive, commensurate with experience and academic accomplishment. We also offer a comprehensive benefit package to employees and eligible dependents, including on-campus housing and children's schooling. All regular ShanghaiTech faculty members will join its new tenure-track system in accordance with international practice for progress evaluation and promotion.
Application Procedure:
Please submit (in English, PDF version) a cover letter, a 2-page research plan, a CV plus copies of 3 most significant publications, and at least of three referees’ names to: hr_siais@shanghaitech.edu.cn. The positions will be open until they are filled by appropriate candidates.
*We will ensure that the information you submit to us is only used for recruitment-related purposes. We will properly protect your data against unauthorized access, use, loss or disclosure. Only authorized personnel from ShanghaiTech are provided access to personal data and such access is granted only to persons who need to have it in order to perform their tasks.
